icon-folder.gif   Conference Reports for NATAP  
 
  53rd ICAAC Interscience Conference on
Antimicrobial Agents and Chemotherapy
September 10-13, 2013, Denver CO
Back grey_arrow_rt.gif
 
 
 
Similar Cognition Outcomes After 48 Weeks for Tenofovir (TDF)/Emtricitabine (FTC) + Atazanavir/Ritonavir (ATV/r)-Experienced HIV+ Patients or Those Simplifying to Abacavir (ABC)/Lamivudine (3TC) + ATV
 
 
  Reported by Jules Levin
53rd Interscience Conference on Antimicrobial Agents and Chemotherapy; September 10-13, 2013; Denver, CO
 
K Robertson,1 P Maruff,2 D Wohl,3 L Bhatti,4 CB Small,5 H Edelstein,6 HH Zhao,7 DA Margolis,7 LL Ross,8 MS Shaefer8 1AIDS Neurological Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; 2Cogstate Ltd, Melbourne, Australia; 3AIDS Clinical Trials Unit, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; 4AIDS Healthcare Foundation, Beverly Hills, CA, USA; 5New York Medical College, Valhalla, NY, USA; 6Alameda County Medical Center, Oakland, CA, USA; 7GlaxoSmithKline, Research Triangle Park, NC, USA; 8ViiV Healthcare, Research Triangle Park, NC, USA

ICAAC1.gif

ICAAC2.gif

ICAAC3.gif

ICAAC4.gif

ICAAC5.gif

ICAAC6.gif